OTCMKTS:OPRX - OptimizeRx Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$16.57 -1.41 (-7.84 %)
(As of 09/21/2018 04:00 PM ET)
Previous Close$16.57
Today's Range$16.49 - $18.10
52-Week Range$2.30 - $18.39
Volume381,280 shs
Average Volume48,981 shs
Market Capitalization$120.07 million
P/E Ratio-78.90
Dividend YieldN/A
OptimizeRx logoOptimizeRx Corporation provides digital health messaging to the pharmaceutical industry. The company offers a direct channel for pharmaceutical companies to communicate with healthcare providers. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies; and brand messaging services, such as various brand awareness and clinical messaging services consisting of brand awareness messages, reminder ads, clinical messages, and unbranded messages that could be targeted by specialty, diagnostic code, and other criteria. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. OptimizeRx Corporation is based in Rochester, Michigan.

Receive OPRX News and Ratings via Email

Sign-up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Business services, not elsewhere classified
SectorComputer and Technology


Debt-to-Equity RatioN/A
Current Ratio3.43
Quick Ratio3.43


Trailing P/E Ratio-78.90
Forward P/E Ratio-207.13
P/E GrowthN/A

Sales & Book Value

Annual Sales$12.13 million
Price / Sales15.90
Cash FlowN/A
Price / CashN/A
Book Value$0.64 per share
Price / Book25.89


EPS (Most Recent Fiscal Year)($0.21)
Net Income$-2,100,000.00
Net Margins-10.02%
Return on Equity-22.08%
Return on Assets-14.36%


Outstanding Shares11,640,000
Market Cap$120.07 million

OptimizeRx (OTCMKTS:OPRX) Frequently Asked Questions

What is OptimizeRx's stock symbol?

OptimizeRx trades on the OTCMKTS under the ticker symbol "OPRX."

How were OptimizeRx's earnings last quarter?

OptimizeRx Co. (OTCMKTS:OPRX) announced its quarterly earnings data on Tuesday, August, 7th. The technology company reported $0.02 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $0.02. The technology company earned $5.10 million during the quarter, compared to analysts' expectations of $4.34 million. OptimizeRx had a negative return on equity of 22.08% and a negative net margin of 10.02%. View OptimizeRx's Earnings History.

What price target have analysts set for OPRX?

3 brokerages have issued 1-year price targets for OptimizeRx's shares. Their predictions range from $17.00 to $18.00. On average, they anticipate OptimizeRx's share price to reach $17.50 in the next year. This suggests a possible upside of 5.6% from the stock's current price. View Analyst Price Targets for OptimizeRx.

What is the consensus analysts' recommendation for OptimizeRx?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OptimizeRx in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for OptimizeRx.

Who are some of OptimizeRx's key competitors?

Who are OptimizeRx's key executives?

OptimizeRx's management team includes the folowing people:
  • Mr. William J. Febbo, CEO & Director (Age 49)
  • Ms. Miriam J. Paramore, Pres (Age 55)
  • Mr. Douglas P. Baker, Chief Financial Officer (Age 61)
  • Mr. Terence J. Hamilton, Sr. VP of Sales (Age 53)
  • Mr. Ed Berger, Sr. VP of Marketing

Who are OptimizeRx's major shareholders?

OptimizeRx's stock is owned by a number of of institutional and retail investors. Top institutional investors include Wolverine Asset Management LLC (6.40%), Perkins Capital Management Inc. (1.36%), Granite Investment Partners LLC (0.40%), Family Management Corp (0.15%) and MAI Capital Management (0.11%). Company insiders that own OptimizeRx stock include Douglas P Baker, Ellen O'connor Vos, Gus D Halas, Miriam J Paramore, Patrick D Spangler, Terrence Hamilton and William J Febbo. View Institutional Ownership Trends for OptimizeRx.

Which major investors are buying OptimizeRx stock?

OPRX stock was purchased by a variety of institutional investors in the last quarter, including Wolverine Asset Management LLC, Perkins Capital Management Inc., Granite Investment Partners LLC, Family Management Corp and MAI Capital Management. Company insiders that have bought OptimizeRx stock in the last two years include Douglas P Baker, Ellen O'connor Vos, Gus D Halas, Miriam J Paramore, Patrick D Spangler, Terrence Hamilton and William J Febbo. View Insider Buying and Selling for OptimizeRx.

How do I buy shares of OptimizeRx?

Shares of OPRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OptimizeRx's stock price today?

One share of OPRX stock can currently be purchased for approximately $16.57.

How big of a company is OptimizeRx?

OptimizeRx has a market capitalization of $120.07 million and generates $12.13 million in revenue each year. The technology company earns $-2,100,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis. OptimizeRx employs 24 workers across the globe.

What is OptimizeRx's official website?

The official website for OptimizeRx is http://www.optimizerx.com.

How can I contact OptimizeRx?

OptimizeRx's mailing address is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. The technology company can be reached via phone at 248-651-6568 or via email at [email protected]

MarketBeat Community Rating for OptimizeRx (OTCMKTS OPRX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  85 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  184
MarketBeat's community ratings are surveys of what our community members think about OptimizeRx and other stocks. Vote "Outperform" if you believe OPRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OPRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel